Dr. Stachenfeld’s lab has paper accepted in Clinical Endocrinology demonstrating endothelial dysfunction in young transgender men.
Gender affirming hormone therapy is the primary medical intervention sought by transgender people. The Stachenfeld lab has demonstrated that androgen therapy in transmen is associated with important cardiovascular changes, including mild hypertension, dyslipidemia and endothelial dysfunction.
